This chapter describes a new combination chemotherapy program that was initiated at the New York Hospital-Cornell Medical Center for large cell lymphoma (LCL). The program, known as COPBLAM (Cyclophosphamide, Oncovin, Prednisone, Bleomycin, Adriamycin, Matulane) was an intensive multidrug regimen ...
acute myeloid leukemia (AML) or acute lymphocytic leukemia (ALL). However, disease relapse is a major cause of treatment failure, and salvage treatment options for these patients are limited. Patients can
black catechu,catechu- extract of the heartwood of Acacia catechu used for dyeing and tanning and preserving fishnets and sails; formerly used medicinally solution- a homogeneous mixture of two or more substances; frequently (but not necessarily) a liquid solution; "he used a solution of peroxide...
Robak T . Purine nucleoside analogues in the treatment of myeloid leukemias. Leuk Lymphoma 2003; 44: 391–409. Article CAS Google Scholar Montillo M, Tedeschi A, Rossi V et al. Successful CD34+ cell mobilization by intermediate-dose Ara-C in chronic lymphocytic leukemia patients treated with...
Hematopoietic cell transplantation (HCT) is a curative approach for myelofibrosis patients, but relapse is a major cause of treatment failure. We investigated the effect of donor lymphocyte infusion (DLI) in 37 patients with molecular (n = 17) or hematological relapse (n = 20) after HCT. Pati...
Treatment of low-grade non-Hodgkin's lymphoma with continuous infusion of low-dose recombinant interleukin-2 in combination with the B-cell-specific monocl... Seven patients with low-grade non-Hodgkin's lymphoma were treated with a combination of a murine monoclonal antibody directed against the ...
In a systematic review on infusion reactions to and infusion rate ofmonoclonal antibodies(mAbs) used in cancer treatment,Rombouts et al. (2020)found that for somemAbs, the incidence of infusion reactions is low or can be lowered by the use of adequate premedication schedules. Moreo...
Students Create TikTok Informercial for AR Exam Glasses Impact of Value-Based Care in Oncology: Insights from COA 2024 Tailoring CLL Treatment: Managing Toxicities and Comorbidities in Targeted Therapies The Evolution and Clinical Applications of MRD Testing in LymphomaRelated...
A total of 229 patients were included, with a male prevalence and an average age of 44 years for adults and 10 years for children. Seventy-nine (34.5%) developed some IRSE, 5.1% of which progressed in severe form to discontinuation of treatment. The most prevalent events in adults were fe...
摘要: Describes the mechanism of continuous infusion flavopiridol in relapsed and refractory mantle cell lymphoma (MCL), a distinct subtype of non-Hodgkin's syndrome. Properties of flavopiridol; Induction of apoptosis in lymphoma cell lines by flavopiridol; Treatment of MCL....